BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19661263)

  • 1. Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice.
    Tonomura Y; Yamamoto E; Kondo C; Itoh A; Tsuchiya N; Uehara T; Baba T
    Hum Exp Toxicol; 2009 May; 28(5):293-300. PubMed ID: 19661263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.
    Zhang Z; Diener RM; Lipman JM
    Int J Toxicol; 2006; 25(4):285-94. PubMed ID: 16815817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the toxicity of a new lipid complex formulation of amphotericin B.
    Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
    J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V; Dromer F; Barge J; Yeni P; Seta N; Molas G; Carbon C
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
    Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
    J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats.
    Uehara T; Tsuchiya N; Masuda A; Torii M; Nakamura M; Yamate J; Maruyama T
    J Appl Toxicol; 2008 Apr; 28(3):388-98. PubMed ID: 17685399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrotoxicity of amphotericin B].
    Deray G; Mercadal L; Bagnis C
    Nephrologie; 2002; 23(3):119-22. PubMed ID: 12087808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat.
    Williams RE; Lock EA
    Toxicology; 2005 Feb; 207(1):35-48. PubMed ID: 15590120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
    Inouye S; Niizato T; Shomura T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of amphotericin B desoxycholate and amphotericin B colloidal dispersion on renal functions and renal morphology in rats.
    Doubek M; Mayer J; Lauschova I; Scheer P; Krejcirova L; Horky D; Doubek J
    Nephrology (Carlton); 2005 Feb; 10(1):57-62. PubMed ID: 15705183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B.
    Hossain MA; Maesaki S; Razzaque MS; Tomono K; Taguchi T; Kohno S
    J Antimicrob Chemother; 2000 Aug; 46(2):263-8. PubMed ID: 10933650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.
    Nahar M; Mishra D; Dubey V; Jain NK
    Nanomedicine; 2008 Sep; 4(3):252-61. PubMed ID: 18502187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and tissue indicators of para-aminophenol nephrotoxicity in sprague-dawley rats.
    Yang A; Trajkovic D; Illanes O; Ramiro-Ibáñez F
    Toxicol Pathol; 2007 Jun; 35(4):521-32. PubMed ID: 17562485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of amphotericin B administered to dogs in a fat emulsion versus five percent dextrose solution.
    Randall SR; Adams LG; White MR; DeNicola DB
    Am J Vet Res; 1996 Jul; 57(7):1054-8. PubMed ID: 8807021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of sodium arsenate in dogs.
    Tsukamoto H; Parker HR; Gribble DH; Mariassy A; Peoples SA
    Am J Vet Res; 1983 Dec; 44(12):2324-30. PubMed ID: 6686417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.